FDA halts one of the first human CRISPR studies before it begins – MIT Technology Review
MIT Technology Review |
FDA halts one of the first human CRISPR studies before it begins
MIT Technology Review FDA hold: But according to a statement on Wednesday from CRISPR Therapeutics, the FDA ordered the company not to proceed with its study until it answers questions about its CRISPR treatment (the company didn't provide any further details about what … Gene-Therapy Company Crispr Drops as FDA Puts Trial on Hold CRISPR Therapeutics and Vertex Provide Update on FDA Review of Investigational New Drug Application for CTX001 … What Makes This CRISPR Stock Better Than the Rest? |
